Key result
AKT1 and NF-κB1 linked to diabesotension hallmarks, highlighting PI3K/Akt and NF-κB as potential therapeutic targets.
Why the study?
The molecular mechanisms underlying diabesotension (diabetes mellitus, obesity, and hypertension) remain poorly understood, and current therapies treat each condition in isolation rather than targeting shared pathways.
The PI3K/Akt and NF-κB pathways may serve as shared molecular drivers and potential therapeutic targets for the triad of diabetes, obesity, and hypertension.
Candidate genes for diabesotension merit validation; leaves open therapeutic targeting of shared pathways.
Diabesotension refers to the pathophysiological association between diabetes mellitus, obesity, and hypertension. Despite their frequent coexistence, the underlying molecular mechanisms driving this triad remain poorly understood, and current therapeutic strategies typically address each condition in isolation rather than targeting their shared pathophysiological pathways. To identify potential hallmark genes underlying diabesotension, we mined gene associations with the triad from the NCBI database. Our analysis revealed that AKT1 and NF-κB1 are implicated in four major hallmarks of diabesotension, such as insulin resistance, inflammation, neurohormonal regulation, and oxidative stress. Collectively, these findings highlight the PI3K/Akt and NF-κB pathways as potential molecular drivers in the pathogenesis of diabesotension. This commentary will provide a comprehensive discussion of these findings within the broader context of current knowledge on the role of PI3K/Akt and NF-κB signaling in diabesotension.
No takes yet. Share an insight, caveat, or question.
Abdullah‐Zawawi et al. (2026) conducted a review in Diabesotension (Type 2 diabetes mellitus, obesity, and hypertension). Targeting PI3K/Akt and NF-κB pathways was evaluated. Bioinformatics analysis revealed that AKT1 and NF-κB1 are implicated in four major hallmarks of diabesotension, highlighting the PI3K/Akt and NF-κB pathways as potential therapeutic targets.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: